KLOW

Chemical & physical information

Peptide class: Multi-peptide research blend

Composition:

• GHK-Cu: 50mg
• BPC-157: 10mg
• TB-500: 10mg
• KPV: 10mg

Total content: 80mg
Form: Lyophilised solid
Typical purity: ≥98–99% (analytical method dependent)

Research context

KLOW is a composite peptide formulation combining four structurally distinct peptides—GHK-Cu, BPC-157, TB-500, and KPV—designed for laboratory investigation into multi-pathway cellular and signalling systems.

This quad-peptide blend is utilised in experimental models where complementary peptide mechanisms are studied in parallel, allowing for investigation into the interaction between regenerative signalling, inflammatory pathway modulation, and structural protein dynamics.

It is commonly investigated in research areas including:

• Multi-peptide signalling interactions
• Cellular repair and regeneration pathways
• Inflammatory signalling and regulatory peptide interactions
• Extracellular matrix and connective tissue models
• Cytoskeletal dynamics and cellular migration processes

The inclusion of KPV, a short-chain regulatory peptide, expands the scope of investigation to include peptide-mediated modulation of inflammatory signalling pathways, alongside the structural and cellular models associated with the other components.

Quality & handling

• Supplied as a lyophilised solid for laboratory preparation
• Manufactured and blended under controlled conditions to support consistency
• Analytical purity verified using standard chromatographic techniques
• Suitable for controlled in vitro and pre-clinical research workflows
• Batch-specific documentation available

For research use only